MARCY L’ETOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announced today the opening of a subsidiary in South Africa. Based in Johannesburg, the new subsidiary will provide support to all of Sub-Saharan Africa. bioMérieux’s 36th subsidiary is another milestone in the company’s international expansion.
